• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Phastar Appoints Chris Schoonmaker as Chief Operations Officer

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills

    Batavia Enters Commercial Manufacturing Business

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Qosina

    CMC Pharmaceuticals

    Biosynth Carbosynth

    IDT Biologika
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Qosina

    CMC Pharmaceuticals

    Biosynth Carbosynth

    IDT Biologika
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Contract Pharma’s 20th Anniversary Series: Vetter

    Oskar Gold of Vetter discusses vital changes in the industry and the science and technology needed to support advanced therapeutics

    Contract Pharma’s 20th Anniversary Series: Vetter
    Oskar Gold, Vetter Pharma International GmbH
    Related CONTENT
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Asymchem
    • Catalent Pharma Solutions
    • Regis Custom Pharma
    Kristin Brooks, Contract Pharma11.13.19
    Of the many vital changes the industry has undergone these past 20 years, the growth in biologics has been momentus. As part of the shift to biologics, a greater understanding of the science and technology that goes into developing and manufacturing these drugs became essential to their success. For example, with many bioloigcs and targeted therapies injectibles have become increasgly prevalent, placing increased demand for CDMOs with aspetic filling and packaging capabilities.

    Oskar Gold, Senior Vice President Key Account Management and Marketing/ Corporate Communications, Vetter Pharma International GmbH, shares with Contract Pharma some of the major pharma/biopharma industry changes in the past 20 years that have impacted contract service providers and some of the changes he anticipates for the future of the industry and outsourcing.  –KB
     
    Contract Pharma: What were some of the major pharma/biopharma industry changes in the past 20 years that have greatly impacted contract service providers? 
     
    Oskar Gold: Vetter has been an active part of the industry for several decades now and for more than 35 years has offered vast experience in the fill and finish business. Of course, over that time we have experienced some strong developments in our industry. The major one that we see is the ever-increasing quality and regulatory requirements of both customers and authorities alike. This is not surprising, but actually a part of the overall evolution taking place throughout the world. Pairing state-of-the-art technology with experienced personnel enable to fulfill those increasing requests.
     
    In the past decades, our customer portfolio has also changed and evolved. Until the early 2000’s, we had a business presence consisting of primarily large pharma customers. When biotechnology became more prolific around the turn of the millennium, we also started to conduct business with smaller biotech companies. Today, we serve biotechnology and pharmaceutical customers both large and small. And, as they are acting more and more in an international way, we also often serve them in the supply of global markets.

    CP: What are some changes you anticipate for the future of the industry and outsourcing?
     
    OG: In the coming years we expect even more emerging biotech companies to launch new medicines due to shifts in their business strategy, which includes maximizing financial returns to investors. This is supported by the fact that as a result of today’s currently low interest rates, they are well-funded with venture capital investments.
     
    A further significant change is taking place within the industry. While identifying a positive development in the number of new drug approvals -- 59 this year vs. 46 in 2018, particularly injectables, it must be stated that the market size for many drug products is getting smaller. Nowadays, a number of medicines  being developed are ever-more targeted, and consequently designed for smaller patient groups, representing a greater understanding and knowledge of precision medicine. Also, the business of data and intelligence is receiving a great deal of attention and is a topic that will continue to evolve. This is primarily due to new methods in the area of digital health.
     
    Based on the oftentimes total cost of ownership calculation of our customers, we also expect the role of strategic partnerships to further increase. Our customers are looking for long-term partners to fulfill their manufacturing needs with a skill set that involves speed, flexibility, innovative approaches and a high level of expertise for complex compounds.
     
    CP: How have service offerings and operations for CDMOs evolved over the years? 
     
    OG: Overall, you can say that complex operations are in good hands when operated by teams with significant experience and a comprehensive service offering. At Vetter, we started the aseptic filling business as a Contract Manufacturing Organization (CMO), and were known for manufacturing large quantities of aseptic drug products that already have or are close to market approval. Over time, we enhanced our offering in order to support our customers from early-on in the drug development process in a comprehensive manner. Today, we provide injectable services from early clinical development through commercial manufacturing, including secondary packaging services and lifecycle management support. Consider, if you will, the metaphor of remodeling a house. Would you use several contractors, each with their own level of expertise or skill set such as plumbing, electricity or carpentry? If there were one contractor who could complete multiple jobs to your satisfaction, you would gladly make that choice, eliminating the need for multiple contracts and relationships.
     
    Regarding the level of operations, drug product manufacturing continues to be more complex, as are the drug substances themselves. As a CDMO serving large and small pharma and biotech companies, you need to offer state-of-the-art technologies that are paired with deep experience in a variety of substance classes, all aimed to meet customers’ expectations.
     
    CP: What global market changes have had the greatest impact on the industry and CDMO services?
     
    OG: Still today, the US market is the leading pharmaceutical market and we expect it to continue to be so. However, looking to the Asian-Pacific (APAC) region, the opening of some markets there has provided new and significant opportunities for pharma and biotech customers as well as their strategic partners. As such, we have noticed a distinct shift taking place both in the nature and manner of the manufacturing in these markets, as well as where these manufactured products are distributed. For example, in prior years the medicines produced within the region were primarily intended for use within the APAC countries. In recent years, we have seen a significant increase in activities that are designed to enlarge the customer base for medicines manufactured within APAC by distributing to countries outside of the APAC region. We expect this activity to further evolve – more proof of the global character for today’s world.



     Oskar Gold
    Oskar Gold is Senior Vice President of Key Account Management and Marketing/ Corporate Communications at Vetter and in charge of the company’s global business development. Before joining Vetter, he managed the European business development of a pharmaceutical component manufacturing company, serving in various functions, including Vice President and Managing Director of group companies. Mr. Gold studied at schools in the United Kingdom, France and in Germany. He completed graduate studies in international business administration at INSEAD, Fontainebleau. Mr. Gold has also taught and lectured on international business strategy and marketing at a European university. He is also a member of the international board of the German Federal Association of the Pharmaceuticals Industry.
    Related Searches
    • contract pharma
    • Outsourcing
    • biotech
    • business development
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Asymchem Asymchem
    Catalent Pharma Solutions Catalent Pharma Solutions
    Regis Custom Pharma Regis Custom Pharma
    CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
    Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma  Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma
    Vetter Vetter's Collaborative Work in Secondary Packaging
    Vetter to Invest in Collaborative Work Robots Vetter to Invest in Collaborative Work Robots
    Vetter provides greater flexibility in secondary packaging through collaborative work Vetter provides greater flexibility in secondary packaging through collaborative work
    Vetter Enhances Secondary Packaging Services Vetter Enhances Secondary Packaging Services
    Vetio Animal Health Vetio Animal Health
    Adare Pharma Solutions Adare Pharma Solutions
    Flamma Arrives in the U.S. Flamma Arrives in the U.S.
    How to Survive and Thrive During CDMO Climate Change How to Survive and Thrive During CDMO Climate Change

    Related Content

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Jessica Kloster, Marketing Manager 10.20.21

    • Asymchem

      Asymchem

      ...
      Mandy Boyd, Asymchem 12.01.20


    • Drug Delivery
      Catalent Pharma Solutions

      Catalent Pharma Solutions

      ...
      Christopher, Director, Global Communications and Marketing 11.25.20

    • APIs | Clinical Trial Materials | Process Validation | QA/QC | Regulatory Affairs

      Regis Custom Pharma

      ...
      Deanna Rentner, Marketing Coordinator 11.12.20

      Loading, Please Wait..
      Trending
      • Regulatory Report: Analytical Procedure Development
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • Pfizer, BioNTech Adapt COVID Vax Against Omicron
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Shimadzu Scientific Instruments Extends HQ Campus
      Breaking News
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      • Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      • EQT Private Equity Acquires SPT Labtech from Battery Ventures
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Kensing Acquires Vitae Naturals
      CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
      Shiitake Mushroom Extract Appears Helpful in HPV Infections
      Coatings World

      Latest Breaking News From Coatings World

      Sheboygan Paint Company Adds Rosey Malchow as Customer Experience Manager
      PPG to Announce Second Quarter 2022 Results July 21
      Evonik Unveils Range of Sustainable Liquid Polybutadienes
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
      NovaXS Unveils New Prototype of Needle-Free Injection Therapy Smart Medical Device
      Meddux Opens New Facility in Boulder, Colorado
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      EQT Private Equity Acquires SPT Labtech from Battery Ventures
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Highlights from Paris Packaging Week
      Walgreens Boots Alliance Decides Not to Sell Boots and No7 Beauty Company Businesses
      WWP Beauty Unveils New Packaging Collections in Collaboration with Eastman
      Happi

      Latest Breaking News From Happi

      Evonik Holds Groundbreaking Ceremony for Commercial Rhamnolipid Production Facility
      CHT USA Hosts Groundbreaking Ceremony for $20 Million US Headquarters Expansion
      Azelis Expands Global Flavors & Fragrances Platform with Acquisition in India
      Ink World

      Latest Breaking News From Ink World

      Temporary Content Title
      Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
      Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Sibress launches FADS3D flexo plate measuring device
      Mike Brown appointed VP for Davis-Standard’s Canadian operations
      Constantia Flexibles introduces chemical resistant recycle-ready laminate
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Suominen Launches Hydraspun Reserve
      Richard Knowlson Receives Lifetime Technical Achievement Award
      Skylark Launches Thicker Label Closure Technology in North American
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Tecomet Appoints Bill Dow as President & CEO
      Medacta, InSilicoTrials Partner on Orthopedic Device Development
      Researchers Develop Microfluidic Sensors to Improve Implant Survival Rates
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Avery Dennison Launches New Dual-Frequency RFID Inlay
      Avery Dennison Highlights New Approach to Apparel with ADX Lab
      trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login